Overall, our findings suggest that the more efficient tumor-targeting capabilities and favorable radiopharmacological profiles of the full-length antibody make it a suitable radiotracer for non-invasive in vivo evaluation of CA125 in EOC. Here, MUC16 is linked to neoplasm.